MRI SOFT TISSUE MOTION CORRECTION SOFTWARE VA10A

K052305 · Siemens Medical Solutions USA, Inc. · LNH · Sep 8, 2005 · Radiology

Device Facts

Record IDK052305
Device NameMRI SOFT TISSUE MOTION CORRECTION SOFTWARE VA10A
ApplicantSiemens Medical Solutions USA, Inc.
Product CodeLNH · Radiology
Decision DateSep 8, 2005
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.1000
Device ClassClass 2
AttributesSoftware as a Medical Device, 3rd-Party Reviewed

Intended Use

The MRI Soft Tissue Motion Correction Software is an adjunctive tool to assist radiologists in interpreting magnetic resonance imaging (MRI) studies. The software is intended to be used in dynamic MRI examinations that consist of multiple image volumes where patient motion may have occurred between serial acquisitions. The MRI Soft Tissue Motion Correction Software performs automatic 2D and/or 3D flexible registration of soft tissue. The registration process enables the correction of motion occuring both within-plane and across planes (3D). By aligning corresponding voxels, the software reduces the impact of patient motion in post-processing techniques including difference (subtraction) images, parametric displays, subtraction volume MIPs and mean-curve analysis. Patient management decisions should not be made solely on the basis of motion corrected images and should always include review of uncorrected images.

Device Story

Software plug-in for clinical MRI workstations; processes serial MRI image volumes to correct for patient motion. Inputs: multiple MRI image volumes. Operation: performs automatic 2D/3D rigid and non-rigid registration to align corresponding voxels between volumes. Outputs: motion-corrected image volumes. Used in clinical settings by radiologists; integrated into workstation workflows (e.g., Numaris VA21A, Leonardo 2004). Provides high-speed and high-quality modes. Corrected images serve as input for post-processing techniques like subtraction images, parametric maps, and mean-curve analysis. Benefits: reduces motion-related artifacts, improving visualization for clinical interpretation. Decisions must include review of original uncorrected images.

Clinical Evidence

Bench testing only. Validation included risk analysis, design reviews, integration testing (system verification), final acceptance testing, and performance testing on clinical data sets.

Technological Characteristics

MRI image processing software plug-in. Performs automatic 2D/3D rigid and non-rigid registration. Operates on clinical workstations (e.g., Numaris VA21A, Leonardo 2004, MammoReport Plus). Provides two operational modes: high-speed and high-quality. Software-based image registration algorithm.

Indications for Use

Indicated for use in dynamic MRI examinations involving multiple image volumes where patient motion occurred between serial acquisitions. Intended as an adjunctive tool for radiologists to assist in interpretation. Contraindicated for use as the sole basis for patient management decisions; uncorrected images must always be reviewed.

Regulatory Classification

Identification

A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).

Special Controls

*Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## SEP - 8 2005 ## 510(k) Summary Ko523os This 510(k) summary of Safety and Effectiveness information is submitted in accordance with the requirements of 21 CFR 807.87(h) and as described in 21 CFR 807.92. | Submitter<br>(510k Owner) | Siemens Medical Solutions USA, Inc.<br>Computer Aided Diagnosis & Therapy Group<br>51 Valley Stream Parkway<br>Malvern, PA 19355<br>Tel: (610) 448-4530<br>Fax: (610) 219-1419 | | | |---------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------|----------------------------------------------------------------------| | Contact | Barry V. Ashar<br>Makromed, Inc.<br>45 Stiles Road<br>Salem, NH 03079<br>Tel: (603) 890-3311<br>Fax: (603) 890-3322<br>bashar@makromed.com | | | | Date of Preparation | July 7, 2005 | | | | Device Trade Name | MRI Soft Tissue Motion Correction Software | | | | Device Common Name | MRI Image Processing Software | | | | Classification Name | Class II: Picture Archiving and Communications System<br>(21 CFR 892.2050)<br>Product Code LLZ: Image Processing System | | | | Substantial Equivalence | CADstream v.4.0 | K043216 | Confirma, Inc. | | | Fusion 7D | K020546 | Mirada Solutions Ltd.<br>(Now Siemens<br>Medical Solutions,<br>Inc.) | | | Leonardo | K040970 | Siemens Medical<br>Solutions USA, Inc. | #### Device Description MRI Soft Tissue Motion Correction Software VA10A provides the functionality to correct soft tissue motion of the MRI image volume between scan times. It supports the correction (registration) of one or more volumes relative to an initially supplied reference volume. {1}------------------------------------------------ The product reduces image deformation and displacement in soft tissues shape and location that may occur due to patient motion in between acquisitions of serial MRJ images. Correction of within imaging plane and across- plane motion is supported. The software corrects for inter-volume rigid displacement and non-rigid deformation between acquired MRI images. This reduces motion-related artifacts in post-processing techniques that use the corrected images as input, for example subtraction images, subtraction volume MIPs, parametric maps and mean-curve analysis. MRI Soft Tissue Motion Correction is a plug-in module for Numaris VA21A clinical workstation (K020991) or equivalent, Leonardo 2004 (K040970) or equivalent and MammoReport Plus (K042868) or equivalent. The visualization application invokes the motion correction device, receives and stores the corrected volumes, and displays the results to the user. MRI Soft Tissue Motion Correction provides both a high quality and a high-speed operational mode. The high-speed mode is optimized for speed, while the high-quality mode is recommended for cases having moderate to large amounts of patient motion between acquisitions and takes longer to complete. #### Intended Use The MRI Soft Tissue Motion Correction Software is an adjunctive tool to assist radiologists in interpreting magnetic resonance imaging (MRI) studies. The software is intended to be used in dynamic MRI examinations that consist of multiple image volumes where patient motion may have occurred between serial acquisitions. The MRI Soft Tissue Motion Correction Software performs automatic 2D and/or 3D flexible registration of soft tissue. The registration process enables the correction of motion occuring both within-plane and across planes (3D). By aligning corresponding voxels, the software reduces the impact of patient motion in post-processing techniques including difference (subtraction) images, parametric displays, subtraction volume MIPs and mean-curve analysis. Patient management decisions should not be made solely on the basis of motion corrected images and should always include review of uncorrected images. #### Comparison with Predicate Devices Automatic flexible non-rigid 3D registration of serial patient MRI acquisitions to minimize the impact of patient motion, the primary feature of VA10A software, has been given 510(k) clearance in CADstream v. 4.0 (K043216, Confirma, Inc.). Similar to CADstream, MRI Soft Tissue Motion Correction VA10A software is designed to analyze MRI studies and uses flexible non-rigid registration in 3D. {2}------------------------------------------------ Automatic flexible non-rigid as well as rigid registration of pairs of anatomical volumetric (MRI-MRI) images to help the clinician obtain better image visualization has been given 510(k) clearance in Fusion7D (K020546, Mirada Solutions, now Siemens Medical Solutions -- CTI Mirada). MRI Soft Tissue Motion Correction also performs non-rigid deformation on MRI image pairs. Leonardo 2004 (K040970, Siemens Medical) has already been given 510(k) clearance for providing a host of MRI image processing features. The MRI Soft Tissue Motion Correction VA10A software is a plug-in module to it and adds one specific functionality to it - motion correction for soft tissue images. All other features remain unchanged. #### Test Summary The following quality assurance measures were applied to the development of the MRI Soft Tissue Motion Correction Software VA10A in accordance with internal procedures: Risk Analysis Requirements Reviews Design Reviews Integration testing (System verification) Final acceptance testing (Validation) Performance testing on clinical data sets (Validation) #### Conclusion ુર્ The MRI Soft Tissue Motion Correction Software VA10A is as safe, as effective, and performs as well as the predicate devices. {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows a logo with a stylized bird figure inside a circle. The bird is drawn with thick, black lines and appears to be in flight. The circle is formed by text that curves around the bird. The text is small and difficult to read, but it seems to be a company or organization name. The overall design is simple and modern. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 SEP - 8 2005 Siemens Medical Solutions USA, Inc. % Ms. Laura Danielson Program Manager, Responsible Third Party Official TÜV Product Service 1775 Old Highway 8 NEW BRIGHTON MN 55112-1891 Re: K052305 Trade/Device Name: MRI Soft Tissue Motion Correction Software VA10A Regulation Number: 21 CFR §892.2050 Regulation Name: Picture archiving and communications system Product Code: LLZ Regulation Number: 21 CFR §892.1000 Regulation Name: Magnetic resonance diagnostic device Product Code: LNH Regulatory Class: II Dated: August 19, 2005 Received: August 24, 2005 Dear Ms. Danielson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050. {4}------------------------------------------------ This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally premated noticate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 | |-----------------|----------------------------------|--------------| | 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 | | 21 CFR 892.xxxx | (Radiology) | 240-276-0120 | | Other | | 240-276-0100 | Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Nancy C. Hogdon Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ # Indications for Use 510(k) Number (if known): צוב במבחמ Device Name: ### MRI Soft Tissue Motion Correction Software VA10A Indications for Use: The MRI Soft Tissue Motion Correction Software is an adjunctive tool to assist radiologists in interpreting magnetic resonance imaging (MRI) studies. The software is intended to be used in dynamic MRI examinations that consist of multiple image volumes where patient motion may have occurred between serial acquisitions. The MRI Soft Tissue Motion Correction Software performs automatic 2D and/or 3D flexible registration of soft tissue. The registration process enables the correction of motion occuring both within-plane and across planes (3D). By aligning corresponding voxels, the software reduces the impact of patient motion in post-processing techniques including difference (subtraction) images, parametric displays, subtraction volume MIPs and mean-curve analysis. Patient management decisions should not be made solely on the basis of motion corrected images and should always include review of uncorrected images. Prescription Use x (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Nancy Schroeder Division Slan-Off Division of Reprodu and Radiological Devices 510(k) हा प्रतिदिन प्रति Siemens Medical Solutions) p. A-1
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...